AmisulprideisanatypicalantipsychoticthatactsasanantagoNISTat5-HT7receptorsandD2/3receptors.Amisulpridealsoexhibitsneuroprotectiveactivity,modulatingβ2-arrestinsignalingtoincreasephosphorylationofAktandGSK-3β,increasingneuriteoutgrowthinvitro.
| CasNo. | 71675-85-9 |
|---|---|
| Purity | ≥98% |
| Formula | C17H27N3O4S |
| FormulaWt. | 369.48 |
| IUPACName | 4-amino-N-[(1-ethylpyrrolidin-2-yl)methyl]-5-ethylsulfonyl-2-methoxybenzamide |
| MeltingPoint | 126-127C |
| Solubility | Ethanol(1mg/ml),DMSO(15mg/ml),DMF(15mg/ml) |
| Appearance | Whitetooffwhitepowder |
| StoreTemp | Ambient |
|---|---|
| ShipTemp | Ambient |
| MSDS | A5234MSDSPDF |
|---|---|
| InfoSheet | A5234InfoSheetPDF |
MeltzerHY.SEROtonergicmechanismsastargetsforexistingandnovelantipsychotics.HandbExpPharmacol.2012;(212):87-124.PMID:23129329.
ParkSW,SeoMK,ChoHY,etal.DifferentialeffectsofamisulprideandhaloperidolondopamineD2receptor-mediatedsignalinginSH-SY5Ycells.Neuropharmacology.2011Sep;61(4):761-9.PMID:21663752.
MöllerHJ.Amisulpride:limbicspecificityandthemechanismofantipsychoticatypicality.ProgNeuropsychopharmacolBiolPsychiatry.2003Oct;27(7):1101-11.PMID:14642970.
